Social Security Disability Insurance (SSDI) in Parkinson’s disease.
Zesiewicz, TA, A Patel-Larson, RA Hauser, and KL Sullivan. 2007. “Social Security Disability Insurance (SSDI) in Parkinson’s Disease.”. Disabil Rehabil.
Search
Search results
374 results found
Levodopa-induced dyskinesia in Parkinson’s disease: epidemiology, etiology, and treatment.
Zesiewicz, TA, CL Ward, RA Hauser, JL Salemi, S Siraj, MC Wilson, and KL Sullivan. 2007. “Levodopa-Induced Dyskinesia in Parkinson’s Disease: Epidemiology, Etiology, and Treatment.”. Curr Neurol Neurosci Rep.
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson’s disease. Movement Disorders 2005;20:1205-1209.
Zesiewicz, TA, KL Sullivan, JL Maldonado, and RA Hauser. 2005. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Movement Disorders 2005;20:1205-1209.”. Movement Disorders.
Levodopa response in early Parkinson’s disease
Hauser, RA, P Auinger, and D Oakes. 2009. “Levodopa Response in Early Parkinson’s Disease”. Mov Disord.
Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep brain stimulation
Zesiewicz, TA, KL Sullivan, M Hoffman, LM Benes, DA Smith, CL Ward, and RA Hauser. 2008. “Delayed Thalamic Intracranial Hemorrhage in an Essential Tremor Patient Following Deep Brain Stimulation”. Eur Neurol.
Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.
Adler, CH, RA Hauser, K Sethi, JN Caviness, L Marlor, M Anderson, and JG Hentz. 2004. “Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.”. Neurology.
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 2003;113:154-161.
Crawford, FC, G Ait-Ghezala, M Morris, MJ Sutcliffe, RA Hauser, AA Silver, and MJ Mullan. 2003. “Translocation Breakpoint in Two Unrelated Tourette Syndrome Cases, Within a Region Previously Linked to the Disorder. Hum Genet 2003;113:154-161.”. Hum Genet.
Clozapine withdrawal symptoms in a Parkinson’s disease patient. Movement Disorders 2002;17:1365-1367.
Zesiewicz, TA, S Borra, and RA Hauser. 2002. “Clozapine Withdrawal Symptoms in a Parkinson’s Disease Patient. Movement Disorders 2002;17:1365-1367.”. Movement Disorders.
Manganese and liver disease. Movement Disorders 1996;11:589.
Hauser, RA, and TA Zesiewicz. 1996. “Manganese and Liver Disease. Movement Disorders 1996;11:589.”. Movement Disorders.
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. NEJM 1995;332:1118-24.
Kordower, JH, TB Freeman, BJ Snow, FJG Vingerhoets, EJ Mufson, PR Sanberg, RA Hauser, et al. 1995. “Neuropathological Evidence of Graft Survival and Striatal Reinnervation After the Transplantation of Fetal Mesencephalic Tissue in a Patient With Parkinson’s Disease. NEJM 1995;332:1118-24.”. NEJM.